Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01808105 · ClinicalTrials.gov registry record · NA
Growth and Tolerance of Infants Fed Infant Formulas
A NA study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- NA
- Development phase
- 424
- Enrollment target
NCT01808105: Completed NA study, sponsored by Abbott Nutrition.
NCT01808105 is a NA study that has completed, run by Abbott Nutrition. The registered enrollment target is 424 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01808105, a NA study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- NA
- Development phase
- 424 participants
- Enrollment target
Study Summary
To evaluate growth and tolerance of healthy term infants fed experimental infant formulas, a commercial infant formula and human breast milk.
Primary Outcome
Weight gain per day
Interventions
- OTHER Human Milk
- OTHER Control Formula
- OTHER Experimental Formula 1
- OTHER Experimental Formula 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 424 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-02 |
| Phase | NA |
What the finished NCT01808105 record still lists
NCT01808105 is an interventional study that assigns participants to a tested intervention. The registered 424 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 4 interventions - of which Human Milk is the first listed.
NCT01808105 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01808105 about?
NCT01808105 is a clinical study titled "Growth and Tolerance of Infants Fed Infant Formulas". To evaluate growth and tolerance of healthy term infants fed experimental infant formulas, a commercial infant formula and human breast milk.
What is the current status of trial NCT01808105?
This trial is currently completed. It is a NA study. The enrollment target is 424 participants. The study started on 2013-04. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01808105?
The interventions under investigation include: Human Milk (OTHER), Control Formula (OTHER), Experimental Formula 1 (OTHER), Experimental Formula 2 (OTHER).
Who is sponsoring clinical trial NCT01808105?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01808105's enrollment target sits among peer trials
424 238th of 2000 higher than 1,763 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05632770 · 424 participants · NA
A Deployment Focused Pragmatic Trial of Optimal Stepped Care Intervention Targeting PTSD and Comorbidity for Acutely Hospitalized Injury Survivors Treated in US Trauma Care Systems
- NCT05733767 · 424 participants · Phase 2
Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study
- NCT06978127 · 424 participants · NA
Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients
- NCT07140913 · 424 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia